Protocol-driven adjustment of ocular hypotensive medication in patients at low risk of conversion to glaucoma

The British Journal of Ophthalmology
Poemen P M ChanNathan Congdon

Abstract

To investigate the safety and potential savings of decreasing medication use in low-risk patients with ocular hypertension (OH). Patients with OH receiving pressure-lowering medication identified by medical record review at a university hospital underwent examination by a glaucoma specialist with assessment of visual field (VF), vertical cup-to-disc ratio (vCDR), central corneal thickness and intraocular pressure (IOP). Subjects with estimated 5-year risk of glaucoma conversion <15% were asked to discontinue ≥1 medication, IOP was remeasured 1 month later and risk was re-evaluated at 1 year. Among 212 eyes of 126 patients, 44 (20.8%) had 5-year risk >15% and 14 (6.6%) had unreliable baseline VF. At 1 month, 15 patients (29 eyes, 13.7%) defaulted follow-up or refused to discontinue medication and 11 eyes (5.2%) had risk >15%. The remaining 69 patients (107 eyes, 50.7%) successfully discontinued 141 medications and completed 1-year follow-up. Mean IOP (20.5±2.65 mm Hg vs 20.3±3.40, p=0.397) did not change, though mean VF pattern SD (1.58±0.41 dB vs 1.75±0.56 dB, p=0.001) and glaucoma conversion risk (7.31±3.74% vs 8.76±6.28%, p=0.001) increased at 1 year. Mean defect decreased (-1.42±1.60 vs -1.07±1.52, p=0.022). One eye (0.47%) ...Continue Reading

References

Apr 1, 1981·Archives of Ophthalmology·H A QuigleyA E Maumenee
Sep 15, 2004·American Journal of Ophthalmology·Robert N WeinrebWilliam B Kannel
Mar 5, 2005·Ophthalmology·Stefano MigliorUNKNOWN European Glaucoma Prevention Study (EGPS) Group
May 17, 2005·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Elliott H MyrowitzTerrence P O'Brien
Jun 21, 2005·La Presse médicale·Marc LabetoulleClaire Le Jeunne
Jan 4, 2006·American Journal of Ophthalmology·George SpaethJohn Keener
Feb 21, 2006·The British Journal of Ophthalmology·H A Quigley, A T Broman
Jul 15, 2006·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Michael Sullivan-MeeClifford Qualls
Nov 11, 2006·Ophthalmology·UNKNOWN Ocular Hypertension Treatment Study GroupMichael A Kass
Aug 19, 2007·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Jennifer M BurrMandy Ryan
Jan 2, 2008·Ophthalmology·William C StewartMarko A Mychaskiw
Sep 20, 2008·Ophthalmology·UNKNOWN Ocular Hypertension Treatment Study Group and the European Glaucoma Prevention Study Group
Jun 13, 2012·Health Technology Assessment : HTA·J M BurrJ Cook
Dec 21, 2013·The British Journal of Ophthalmology·Yemisi TakwoingiUNKNOWN Surveillance for Ocular Hypertension Study Group

❮ Previous
Next ❯

Citations

Nov 17, 2015·Current Opinion in Ophthalmology·Anja Tuulonen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.